This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (4)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in this journal  Topic Collections  • Prion Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Katharina Stoeck, MD; Monika Bodemer; Barbara Ciesielczyk; Bettina Meissner, MD; Mario Bartl, MD; Uta Heinemann; Inga Zerr, MD

Arch Neurol. 2005;62:1591-1594.

Background  In neurodegenerative diseases, increasing attention has been focused on inflammatory mediators such as pro-inflammatory and anti-inflammatory cytokines and their potential influence in the process of neurodegeneration. In prion diseases, much data has been gained on the cell culture and animal disease models level, but only limited information is available on humans affected by Creutzfeldt-Jakob disease (CJD).

Objective  To obtain data on anti-inflammatory cytokines interleukin 4 and interleukin 10 in the cerebrospinal fluid of patients with CJD, patients with other dementia, and nondemented neurological patients and controls.

Design  Cerebrospinal fluid samples were collected from CJD patients and control subjects, and concentrations of the anti-inflammatory cytokines interleukin 4 and interleukin 10 were determined using an enzyme-linked immunosorbent assay.

Patients  Cerebrospinal fluid samples from 61 patients were analyzed. The group was composed of patients with CJD (n = 20), patients with other forms of dementia (n = 10), patients with motoneuron disease (n = 6), patients with normal pressure hydrocephalus (n = 5), and control subjects (n = 20).

Results  Interleukin 10 levels were significantly elevated in the cerebrospinal fluid of CJD patients (median, 9.8 pg/mL). The elevation was significant to other dementia (median, 7.9 pg/mL, P<.05), motoneuron disease (median, 7.9 pg/mL, P<.05), normal pressure hydrocephalus (median, 7.0 pg/mL, P<.05), and controls (median, 1.3 pg/mL, P<.001). Levels of interleukin 4 were significantly elevated in cerebrospinal fluid of patients with CJD (median, 26.4 pg/mL) compared with control subjects (median, 6.2 pg/mL, P<.001) and patients with a motoneuron disease (median, 10.5 pg/mL, P<.001)

Conclusions  Elevated levels of the anti-inflammatory cytokines interleukin 4 and interleukin 10 in cerebrospinal fluid of patients with CJD are new findings. The data of the present study provide a clue toward the possible role of cytokines as immunological modifiers in the neurodegenerative process of CJD.

Author Affiliations: Department of Neurology, University Hospital Göttingen, Göttingen, Germany.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Interleukin 4 and Interleukin 10 in Creutzfeldt-Jakob Disease
Yasuo Iwasaki, Shigeji Baba, and Ken Ikeda
Arch Neurol. 2006;63(6):911.
EXTRACT | FULL TEXT  

Interleukin 4 and Interleukin 10 in Creutzfeldt-Jakob Disease—Reply
Katharina Stoeck and Inga Zerr
Arch Neurol. 2006;63(6):911.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Accelerated Prion Disease Pathogenesis in Toll-Like Receptor 4 Signaling-Mutant Mice
Spinner et al.
J. Virol. 2008;82:10701-10708.
ABSTRACT | FULL TEXT  

Genes contributing to prion pathogenesis
Tamguney et al.
J. Gen. Virol. 2008;89:1777-1788.
ABSTRACT | FULL TEXT  

Interleukin 4 and interleukin 10 in Creutzfeldt-Jakob disease.
Iwasaki et al.
Arch Neurol 2006;63:911-911.
FULL TEXT